SAN DIEGO--(BUSINESS WIRE)--SmallCapInsights.com, a leading investment newsletter committed to discovering tomorrow’s smallcap breakthroughs, has announced the online release of an audio interview with the CEO of MultiCell Technologies (OTCBB:MCET), a developer of first-in-class drugs based on advanced immune system modulation and other proprietary technologies.
